ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,178.00
1.88%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,590.82
0.79%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Ocuphire Pharma Inc (OCUP)

  7. Ocuphire Pharma Inc (OCUP) 뉴스

OCUP Ocuphire Pharma Inc

1.80
0.16 (9.76%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Ocuphire Pharma Inc OCUP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.16 9.76% 1.80 09:00:00
개장가 저가 고가 종가 전일 종가
1.67 1.65 1.99 1.85 1.64
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/03/202407:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/03/202422:21EDGAR2Form 8-K - Current report
17/02/202406:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/02/202406:03EDGAR2Form 8-K - Current report
15/02/202408:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202408:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202408:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/02/202408:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
23/01/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202406:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/01/202407:00EDGAR2Form S-3 - Registration statement under Securities Act of..
04/01/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:45EDGAR2Form 8-K - Current report
14/11/202307:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:12EDGAR2Form 8-K - Current report
03/11/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202322:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202321:44EDGAR2Form 8-K - Current report
02/11/202305:21EDGAR2Form 8-K - Current report
27/09/202321:45EDGAR2Form 8-K - Current report
27/09/202321:00PRNUSViatris and Ocuphire Pharma Announce FDA Approval of..
14/08/202321:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/08/202322:27EDGAR2Form 8-K - Current report
11/08/202321:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/08/202300:21EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
OCUP
Ocuphire Pharma
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유